SGP Insider Trading Activity and SEC Form 4 Filings
SGP insider trading summary
Over the past 12 months, insiders at SpyGlass Pharma, Inc. (SGP) reported 5 open-market purchases worth $13.2M by 4 insiders and no sales on SEC Form 4. Net insider buying was $13.2M.
Latest SGP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 9, 2026 | Kirk G. Nielsen | Insider | Buy | $2.6M (165,000 @ $16.00) |
| Feb 9, 2026 | Vensana Capital I, L.P. | Insider | Buy | $2.6M (165,000 @ $16.00) |
| Feb 9, 2026 | Kirk G. Nielsen | Insider | Buy | $2.6M (165,000 @ $16.00) |
| Feb 9, 2026 | Vensana Capital I GP, LLC | Insider | Buy | $2.6M (165,000 @ $16.00) |
| Feb 9, 2026 | Peter Justin Klein | Insider | Buy | $2.6M (165,000 @ $16.00) |
| Nov 21, 2008 | Thomas J Colligan | Director | Buy | $69K (5,000 @ $13.88) |
| Oct 29, 2008 | Jack L Stahl | Director | Buy | $70K (5,000 @ $14.05) |
| Oct 28, 2008 | Jack L Stahl | Director | Buy | $66K (5,000 @ $13.27) |
| Apr 24, 2008 | Fred Hassan | Chairman and CEO | Buy | $91K (5,000 @ $18.21) |
| Apr 24, 2008 | Fred Hassan | Chairman and CEO | Buy | $153K (8,400 @ $18.22) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.